位置:首页 > 蛋白库 > PRIC2_MOUSE
PRIC2_MOUSE
ID   PRIC2_MOUSE             Reviewed;         845 AA.
AC   Q80Y24; A6H652;
DT   01-FEB-2005, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 3.
DT   03-AUG-2022, entry version 133.
DE   RecName: Full=Prickle-like protein 2;
DE   Flags: Precursor;
GN   Name=Prickle2;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Adams M.D., Myers E.W., Smith H.O., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   IDENTIFICATION, AND CHARACTERIZATION.
RX   PubMed=12525887;
RA   Katoh M., Katoh M.;
RT   "Identification and characterization of human PRICKLE1 and PRICKLE2 genes
RT   as well as mouse Prickle1 and Prickle2 genes homologous to Drosophila
RT   tissue polarity gene prickle.";
RL   Int. J. Mol. Med. 11:249-256(2003).
RN   [4]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-92, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain;
RX   PubMed=16452087; DOI=10.1074/mcp.t500041-mcp200;
RA   Trinidad J.C., Specht C.G., Thalhammer A., Schoepfer R., Burlingame A.L.;
RT   "Comprehensive identification of phosphorylation sites in postsynaptic
RT   density preparations.";
RL   Mol. Cell. Proteomics 5:914-922(2006).
RN   [5]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-319; SER-321; SER-322;
RP   THR-535; THR-537; THR-540; SER-544; SER-547; SER-608; SER-643 AND SER-732,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Brain, Kidney, and Lung;
RX   PubMed=21183079; DOI=10.1016/j.cell.2010.12.001;
RA   Huttlin E.L., Jedrychowski M.P., Elias J.E., Goswami T., Rad R.,
RA   Beausoleil S.A., Villen J., Haas W., Sowa M.E., Gygi S.P.;
RT   "A tissue-specific atlas of mouse protein phosphorylation and expression.";
RL   Cell 143:1174-1189(2010).
RN   [6]
RP   TISSUE SPECIFICITY, AND DISRUPTION PHENOTYPE.
RX   PubMed=21276947; DOI=10.1016/j.ajhg.2010.12.012;
RA   Tao H., Manak J.R., Sowers L., Mei X., Kiyonari H., Abe T., Dahdaleh N.S.,
RA   Yang T., Wu S., Chen S., Fox M.H., Gurnett C., Montine T., Bird T.,
RA   Shaffer L.G., Rosenfeld J.A., McConnell J., Madan-Khetarpal S.,
RA   Berry-Kravis E., Griesbach H., Saneto R.P., Scott M.P., Antic D., Reed J.,
RA   Boland R., Ehaideb S.N., El-Shanti H., Mahajan V.B., Ferguson P.J.,
RA   Axelrod J.D., Lehesjoki A.E., Fritzsch B., Slusarski D.C., Wemmie J.,
RA   Ueno N., Bassuk A.G.;
RT   "Mutations in prickle orthologs cause seizures in flies, mice, and
RT   humans.";
RL   Am. J. Hum. Genet. 88:138-149(2011).
CC   -!- SUBCELLULAR LOCATION: Nucleus membrane {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Expressed in the hippocampus and cerebral cortex.
CC       {ECO:0000269|PubMed:21276947}.
CC   -!- DISRUPTION PHENOTYPE: Null mice are viable, but show an increased
CC       seizure rate compared to heterozygous mice, indicating a dosage effect.
CC       Heterozygous Prickle2 +/- mice have a decreased seizure threshold
CC       compared to wild-type. {ECO:0000269|PubMed:21276947}.
CC   -!- SIMILARITY: Belongs to the prickle / espinas / testin family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH50793.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH466523; EDK99322.1; -; Genomic_DNA.
DR   EMBL; BC145754; AAI45755.1; -; mRNA.
DR   EMBL; BC050793; AAH50793.1; ALT_INIT; mRNA.
DR   CCDS; CCDS51854.1; -.
DR   RefSeq; NP_001127931.1; NM_001134459.1.
DR   RefSeq; NP_001127932.1; NM_001134460.2.
DR   RefSeq; NP_001127933.1; NM_001134461.1.
DR   AlphaFoldDB; Q80Y24; -.
DR   SMR; Q80Y24; -.
DR   BioGRID; 232537; 54.
DR   IntAct; Q80Y24; 2.
DR   MINT; Q80Y24; -.
DR   STRING; 10090.ENSMUSP00000109073; -.
DR   iPTMnet; Q80Y24; -.
DR   MaxQB; Q80Y24; -.
DR   PaxDb; Q80Y24; -.
DR   PRIDE; Q80Y24; -.
DR   ProteomicsDB; 291560; -.
DR   Antibodypedia; 50866; 76 antibodies from 20 providers.
DR   DNASU; 243548; -.
DR   Ensembl; ENSMUST00000113445; ENSMUSP00000109072; ENSMUSG00000030020.
DR   Ensembl; ENSMUST00000113446; ENSMUSP00000109073; ENSMUSG00000030020.
DR   Ensembl; ENSMUST00000113447; ENSMUSP00000109074; ENSMUSG00000030020.
DR   GeneID; 243548; -.
DR   KEGG; mmu:243548; -.
DR   UCSC; uc009cyx.2; mouse.
DR   CTD; 166336; -.
DR   MGI; MGI:1925144; Prickle2.
DR   VEuPathDB; HostDB:ENSMUSG00000030020; -.
DR   eggNOG; KOG1704; Eukaryota.
DR   GeneTree; ENSGT00940000153629; -.
DR   HOGENOM; CLU_008937_5_0_1; -.
DR   InParanoid; Q80Y24; -.
DR   OMA; LHQSFDF; -.
DR   OrthoDB; 997264at2759; -.
DR   TreeFam; TF313265; -.
DR   BioGRID-ORCS; 243548; 2 hits in 70 CRISPR screens.
DR   ChiTaRS; Prickle2; mouse.
DR   PRO; PR:Q80Y24; -.
DR   Proteomes; UP000000589; Chromosome 6.
DR   RNAct; Q80Y24; protein.
DR   Bgee; ENSMUSG00000030020; Expressed in piriform cortex and 236 other tissues.
DR   ExpressionAtlas; Q80Y24; baseline and differential.
DR   Genevisible; Q80Y24; MM.
DR   GO; GO:0016327; C:apicolateral plasma membrane; IDA:MGI.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0016328; C:lateral plasma membrane; IDA:MGI.
DR   GO; GO:0031965; C:nuclear membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IDA:MGI.
DR   GO; GO:0031175; P:neuron projection development; IMP:MGI.
DR   CDD; cd09415; LIM1_Prickle; 1.
DR   CDD; cd09418; LIM2_Prickle; 1.
DR   CDD; cd09420; LIM3_Prickle; 1.
DR   CDD; cd09827; PET_Prickle; 1.
DR   InterPro; IPR033725; LIM1_prickle.
DR   InterPro; IPR033726; LIM2_prickle.
DR   InterPro; IPR033727; LIM3_prickle.
DR   InterPro; IPR010442; PET_domain.
DR   InterPro; IPR033723; PET_prickle.
DR   InterPro; IPR001781; Znf_LIM.
DR   Pfam; PF00412; LIM; 3.
DR   Pfam; PF06297; PET; 1.
DR   SMART; SM00132; LIM; 3.
DR   PROSITE; PS00478; LIM_DOMAIN_1; 2.
DR   PROSITE; PS50023; LIM_DOMAIN_2; 3.
DR   PROSITE; PS51303; PET; 1.
PE   1: Evidence at protein level;
KW   LIM domain; Lipoprotein; Membrane; Metal-binding; Methylation; Nucleus;
KW   Phosphoprotein; Prenylation; Reference proteome; Repeat; Zinc.
FT   CHAIN           1..842
FT                   /note="Prickle-like protein 2"
FT                   /id="PRO_0000075892"
FT   PROPEP          843..845
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000396719"
FT   DOMAIN          18..126
FT                   /note="PET"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00636"
FT   DOMAIN          128..193
FT                   /note="LIM zinc-binding 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          193..253
FT                   /note="LIM zinc-binding 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   DOMAIN          253..317
FT                   /note="LIM zinc-binding 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00125"
FT   REGION          314..346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          483..546
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          558..581
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          642..700
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          823..845
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        314..328
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        329..346
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        519..546
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        665..682
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         92
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:16452087"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         321
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         322
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         535
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         537
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         540
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         544
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         547
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         608
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         643
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         732
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0007744|PubMed:21183079"
FT   MOD_RES         842
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           842
FT                   /note="S-farnesyl cysteine"
FT                   /evidence="ECO:0000250"
FT   CONFLICT        273
FT                   /note="G -> D (in Ref. 2; AAH50793)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   845 AA;  95781 MW;  234C14897AD3F261 CRC64;
     MVTVMPLEME KTISKLMFDF QRSSTSDDDS GCALEEYAWV PPGLKPEQVH QYYSCLPEEK
     VPYVNSAGEK LRIKQLLHQL PPHDNEVRYC NSLDEEEKRE LKLFSNQRKR ENLGRGNVRP
     FPVTMTGAIC EQCGGQIKGG DIAVFASRAG HGICWHPPCF VCTVCNELLV DLIYFYQDGK
     IYCGRHHAEC LKPRCAACDE IIFADECTEA EGRHWHMRHF CCFECETVLG GQRYIMKEGR
     PYCCHCFESL YAEYCDTCAQ HIGIDQGQMT YDGQHWHATE TCFCCAHCKK SLLGRPFLPK
     QGQIFCSRAC SAGEDPNGSD SSDSAFQNAR AKESRRSAKI GKNKGKTEEA MLNQHSQLQV
     SSNRLSADVD PLSVQMDLLS LSSQTPSLNR DPIWRSREEP FHYGNKMEQN QSQSPLQLLS
     QCNIRTSYSP GGQGAGAQPD MWAKHFSNPK RSSSMALKGH GGSFIQECRE DYYPGRLMSQ
     ESYSDMSSQS FNETRGSIPV PKYEEEEEEE EGGISTQQCR PRRPLSSLKY TEDMTPTEQT
     PRGSMESLAL SNATGLSAEG GAKRQEHLSR FSMPDLSKDS GMNVSEKLSN MGTLNSSMQF
     RSAESVRSLL SAQQYQEMEG NLHQLSNPLG YRDLQSHGRM HQSFDFDGGI ASSKLPGQEG
     VHIQPMSERT RRRTTSRDDN RRFRPHRSRR SRRSRSDNAL HLASEREVIA RLKERPPLRA
     REDYDQFMRQ RSFQESLGQG SRRDLYSQCP RTVSDLALQN AFGERWGPYF TEYDWCSTCS
     SSSESDNEGY FLGEPIPQPA RLRYVTSDEL LHKYSSYGVP KSSTLGGRGQ LHSRKRQKSK
     NCIIS
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024